Abstract
The multidrug resistance of glioma impedes chemo-radiotherapy and leads to adverse outcomes. In the present study, the doxorubicin (DOX)-resistant glioma SHG44/DOX cell line was established to investigate the effects and mechanisms of Salvia miltiorrhiza ligustrazine (SML), a traditional Chinese medicine, on the reversal of DOX-resistance. The SHG44/DOX cells grew continually in 0.1 µg/ml DOX and expressed increased levels of mRNA of multidrug resistance genes [multidrug resistance 1 (MDR1), multidrug resistance-associated protein 1 (MRP1) and lung resistance protein (LRP)] compared with the parental SHG44 cells. Treatment with DOX plus SML suppressed proliferation and promoted early apoptotic rates in SHG44/DOX cells, although treatment with DOX alone failed to inhibit SHG44/DOX cells. In addition, the levels of MDR1, MRP1 and LRP were downregulated by this traditional Chinese medicine, coupled with increased intracellular DOX concentrations. Tumor-bearing nude mouse models were also established using SHG44/DOX cells, and it was demonstrated that the tumor volumes and proliferation indexes were lower in the DOX plus SML group compared with the DOX alone group. The present data demonstrated that treatment with SML was able to r...Continue Reading
References
Jan 3, 2006·FEBS Letters·Roger G Deeley, Susan P C Cole
Mar 21, 2007·Critical Reviews in Oncology/hematology·Susan D P W M de Jonge-PeetersEdo Vellenga
Sep 18, 2008·Cancer Investigation·Giselle Pinto de FariaRaquel Ciuvalschi Maia
Apr 3, 2009·Journal of Cancer Research and Clinical Oncology·Yao JinLan Qing
Apr 28, 2010·The Journal of Pharmacology and Experimental Therapeutics·Sagar AgarwalWilliam F Elmquist
May 7, 2010·CA: a Cancer Journal for Clinicians·Erwin G Van MeirJeffrey J Olson
Jun 23, 2010·Chinese Medicine·Tsai-Hui Lin, Ching-Liang Hsieh
Sep 18, 2010·International Journal of Cancer. Journal International Du Cancer·Yi GongJin-Rong Zhou
Aug 23, 2011·Journal of Ethnopharmacology·Sang-Hun LeeByung-Cheol Lee
Jun 20, 2012·Oncology Reports·Keming YuJing Zhuang
Jun 7, 2013·Molecular and Cellular Biochemistry·Liang LuXiaoyan Shen
Jul 10, 2013·Journal of Cellular Biochemistry·Song ChenYuan Cheng
Aug 6, 2013·Molecular Medicine Reports·Yong WangWei Zhao
Sep 26, 2013·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Ning HuangYuan Cheng
Oct 15, 2013·Medicinal Research Reviews·Xiuping ChenYitao Wang
Nov 7, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Y DengF F Y Lam
Jan 25, 2014·Nature Reviews. Cancer·Dominik SturmStefan M Pfister
Feb 8, 2014·PloS One·Xiaoxiao CaiJing Zhuang
Aug 31, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Tao HuChi Hin Cho
Nov 15, 2014·The American Journal of Chinese Medicine·Yu LiuJinglai Qu
Dec 3, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jiangxia CaiYalin Dong
Jan 15, 2015·The American Journal of Chinese Medicine·Jing LuoKeji Chen
Feb 6, 2015·BMC Genomics·Li-Ling LinHsueh-Fen Juan
Jun 2, 2015·Expert Review of Neurotherapeutics·Brenda AuffingerMaciej S Lesniak
Jun 13, 2015·Drug Development and Industrial Pharmacy·Manu Smriti Singh, Alf Lamprecht
Jul 3, 2015·Frontiers in Neuroscience·Amanda TivnanJochen H M Prehn
Jul 21, 2015·PloS One·Pleun C M van PoppelGerard A Rongen
Nov 5, 2015·Journal of Neuro-oncology·Rong ZhangTeiji Tominaga